About the Journal

Journal of Pharmacy and Pharmacoeconomics (JPP) is a peer-reviewed, multidisciplinary scientific journal dedicated to advancing knowledge in clinical pharmacy, drug utilization, and health economic evaluation. The journal provides a platform for researchers, clinicians, policymakers, and healthcare professionals to disseminate high-quality research that enhances therapeutic decision-making and healthcare efficiency.

JPP emphasizes the integration of clinical outcomes, economic evaluation, and patient-centered care to support evidence-based pharmaceutical practice. The journal aims to improve healthcare systems by promoting rational drug use and value-based healthcare strategies.

Aims of the Journal

  • Promote evidence-based decision-making in pharmacy and healthcare.
  • Publish research on cost-effectiveness and value-based healthcare.
  • Support the rational use of medicines and healthcare resources.
  • Encourage interdisciplinary research linking clinical pharmacy and pharmacoeconomics.
  • Provide insights for health policy development and pharmaceutical management.

Scope of the Journal

  • Clinical Pharmacy & Therapeutics: Medication therapy management, clinical outcomes, drug safety, and pharmacovigilance.
  • Pharmacoeconomics: Cost-effectiveness, cost-utility, cost-benefit, and budget impact analyses.
  • Drug Utilization Research: Prescription patterns, rational drug use, and pharmacoepidemiology.
  • Health Policy & Systems: Pharmaceutical policy, regulation, access to medicines, and healthcare financing.
  • Outcomes Research: Quality of life studies, patient-reported outcomes, and comparative effectiveness research.
  • Value-Based Healthcare: Health technology assessment (HTA), pricing, reimbursement, and real-world evidence.

Types of Articles Published

  • Research Articles: Full-length studies including clinical trials, observational studies, and economic evaluations.
  • Review Articles: Narrative reviews, systematic reviews, and meta-analyses.
  • Policy and Practice Papers: Health policy analysis and pharmaceutical care models.
  • Short Communications: Brief reports of significant or preliminary findings.
  • Case Reports: Clinical or pharmacoeconomic case analyses.
  • Commentary / Perspectives: Expert opinions and discussions on emerging issues.
  • Letters to the Editor: Scholarly critiques and discussions.